Dual Nanobody-Redirected and Bi-specific CD13/TIM3 CAR T Cells Eliminate AML Xenografts Without Toxicity to Human HSCs.
Oncoimmunology（2025）
Key words
Acute Myeloid Leukemia (AML),nanobody CARTs,CD13-TIM3,reduced toxicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined